Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04836507
Status:
RECRUITING
Last Update Posted:
2021-05-03
First Post:
2021-04-05
Brief Title:
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients
Sponsor:
Curocell Inc
Organization:
Curocell Inc
Study Overview
Official Title:
An Open-label Multi-center Single-arm Phase 12 Study to Assess Tolerability Safety and Efficacy of CRC01 in Adult Patients With Relapsed or Refractory Large B-cell Lymphoma
Status:
RECRUITING
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multi-center phase III study to determine the efficacy and safety of CRC01 in adult patients with relapsed or refractory large B-cell lymphoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None